Toggle Main Menu Toggle Search

Open Access padlockePrints

Evaluation of antiarrhythmic drug efficacy in patients with an ICD - Unlimited potential or replete with complexity and problems?

Lookup NU author(s): Dr Sushma Saksena


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


A report from a Study group, proposed by A. J. Camm, London, of the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology; co-sponsored by the North American Society of Pacing and Electrophysiology. The Study Group was convened on 29 August 1997 at Saltsjobaden, near Stockholm. The meeting was chaired by A. J. Camm, London, and C. M. Pratt, Houston. Based on the presentation and discussions, a first draft of the documents was prepared by C. Pratt and J. Camm which was then circulated to all members three times for their review. All members of the Study Group approved the final manuscript. This report represents the opinion of the members of this Study Group and does not necessarily reflect the official position of either society. The meeting of the Study Group was made possible by unrestricted educational grants from Medtronic, Guidant, Proctor & Gamble, Berlex and Sanofi. Also, presented, in part, at the Cardio-Renal Drugs Advisory Board meeting of the Food and Drug Administration, Bethesda, Maryland, on 30 April 1999.

Publication metadata

Author(s): Pratt CM, Camm AJ, Bigger JT, Breithardt G, Campbell RWF, Epstein AE, Kappenberger LJ, Kuck KH, Pocock S, Saksena S, Waldo AL

Publication type: Review

Publication status: Published

Journal: European Heart Journal

Year: 1999

Volume: 20

Issue: 21

Pages: 1538-1552

Print publication date: 01/11/1999

ISSN (print): 0195-668X

ISSN (electronic): 1522-9645


DOI: 10.1053/euhj.1999.1850